BackgroundIn China, breast cancer is the most frequently diagnosed cancer in women. Marked disparities between urban and rural populations have been reported for breast cancer incidence and survival. In 2009, China launched a breast cancer screening programme for women living in rural areas who were...
Population screening programs have contributed to reduced breast cancer mortality, but disadvantaged or vulnerable groups may not have shared these improve
Harms of breast cancer screening: systematic review to update the 2009 US Preventive Services Task Force recommendation. Ann Intern Med. 2016;164(4):256-267. doi:10.7326/M15-0970PubMedGoogle ScholarCrossref 10. Siu AL; US Preventive Services Task Force. Screening for breast cancer: ...
et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-129912953083Google ScholarCrossref 4. Vainio H, Bianchini F. Breast Cancer Screening: International Agency for ...
International Journal of Environmental Research and Public Health Article Breast Cancer Screening Programmes across the WHO European Region: Differences among Countries Based on National Income Level Emma Altobelli 1,2,*, Leonardo Rapacchietta 1, Paolo Matteo Angeletti 1, Luca Barbante 1, Filippo ...
Screening for Breast Cancer When you go to the grocery store, you knock on a watermelon and squeeze a tomato before buying it. Why? To test it out to see if it looks, feels, or sounds right, whatever the case may be. You screen for problems so that you don't buy something rotten...
It is important that the introduction of breast screening is closely monitored. The anticipated effect on breast cancer mortality will take 10 years or more fully to emerge, and will only occur if a succession of more short-term end points are met. Data from the Swedish two-county randomised...
gynecologicmalignancies.Ovarian neoplasmscan be broadly divided into three categories:epithelial tumors,sex cord stromal tumors, andgerm cell tumors.Epithelial ovarian canceris responsible for the preponderance of morbidity and mortality and has been the focus of multiple studies evaluating screening programs...
Dr. Laura Biganzoli is Co-Chair of the European Breast Cancer Conference and Director of the Breast Center at Santo Stefano Hospital, Prato, Italy, and was not involved in the research. She said, "We know that breast screening programs are beneficial, but we also know that some people wil...
Restarting breast cancer screening programs after the COVID-19 disruption will be challenging given a trade-off between minimizing excess mortality and strain on programs, according to a modeling study.